75 results
6-K
EX-99.1
GMAB
Genmab
2 May 24
Genmab Announces Financial Results for the First Quarter of 2024
11:08am
, Genmab’s proprietary pipeline of investigational medicines, where we are responsible for at least 50% of development, consisted of ten antibodies … in the U.S. and Japan, with AbbVie responsible for further global commercialization. Genmab records sales in the U.S. and Japan and receives tiered
6-K
EX-99.1
GMAB
Genmab
15 Feb 24
Notice to Convene the Annual General Meeting of Genmab A/S
7:23pm
transformation of large and complex companies, including digital transformations and digitally based innovation, and has been responsible for major … , development and commercialization in the pharmaceutical industry, where he has been responsible for the development of several medicines approved globally
6-K
EX-99.1
kzio4us
14 Feb 24
Genmab 2023 Annual Report
12:30pm
6-K
EX-99.1
ir7f4
14 Feb 24
Genmab 2023 Annual Report
12:30pm
6-K
EX-99.1
stis 19v47juhfe405b
7 Nov 23
Genmab Announces Financial Results for the First Nine Months of 2023
11:12am
6-K
EX-99.1
hslnx66rmcvy
25 Sep 23
Current report (foreign)
8:53am
6-K
EX-99.1
csw6hxitx6h7pgjb
3 Aug 23
Genmab Announces Financial Results for the First Half of 2023
11:16am
6-K
EX-99.1
bqdxxijrci4mvi
21 Jul 23
Current report (foreign)
9:08am
6-K
EX-99.1
yut5ylq
27 Jun 23
Current report (foreign)
6:54pm
6-K
EX-99.1
02p51q wdyivqzvfqz
10 May 23
Genmab Announces Financial Results for the First Quarter of 2023
11:23am
6-K
EX-99.1
86eof8itcavep
9 Nov 22
Genmab Announces Financial Results for the First Nine Months of 2022
11:31am
6-K
EX-99.1
7vyslj01wx6
10 Aug 22
Genmab Announces Financial Results for the First Half of 2022
11:25am
6-K
EX-99.1
1z8wzot14yq
18 Jul 22
Current report (foreign)
11:08am
6-K
EX-99.1
u4o9a3bv
11 May 22
Genmab Announces Financial Results for the First Quarter of 2022
11:24am
6-K
EX-99.1
om5f iwku
24 Feb 22
Notice to Convene the Annual General Meeting of Genmab A/S
9:15am